| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |